Thursday, July 19, 2012

ELS Review of USFDA Site Inspections in India Reveals Strong Focus on Quality



A review of site inspection data by Executive Director of Excel Life Sciences, Dr. Saurendra Das, has revealed that Indian sites are passing muster with one of the world’s most stringent regulatory agencies. Over a 7 year period and more than 30 site inspections, investigative sites in India have not received a single, OAI – Official Action Initiated, which is the most significant and negative of findings the agency can levy following an inspection. ELS has been directly involved with 4 of the inspections. For additional highlights, see the included slide/image. To find out how Excel Life Sciences can help your sites perform better In India, please visit our website

No comments:

Post a Comment